Larimar Therapeutics (LRMR) Debt Ratio (2014 - 2020)
Larimar Therapeutics' (LRMR) quarterly Debt Ratio came in at 0.09 in Q1 2020, down 25.43% YoY from 0.12 in Q2 2019, and down 94.37% on a QoQ basis from 1.63 in Q4 2019.
Larimar Therapeutics (LRMR) Debt Ratio (2014 - 2020) Analysis & Trends
Larimar Therapeutics (LRMR) has 7 years of Debt Ratio data on file, last reported at 0.09 in Q1 2020.
- Quarterly Debt Ratio fell 25.43% year-over-year to 0.09 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was 0.09 (down 25.43% YoY) and the FY2019 annual result came in at 1.63, up 1204.93% from the prior year.
- Debt Ratio slipped to 0.09 in Q1 2020, from 1.63 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 1.63 in Q4 2019 to a low of 0.01 in Q3 2016.
- A 5-year average of 0.23 and a median of 0.12 in 2019 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2016 — Debt Ratio tumbled 58.09% — and 2019, when it jumped 1204.93%.
- Tracing LRMR's Debt Ratio over 5 years: stood at 0.01 in 2016, then surged by 2154.32% to 0.19 in 2017, then tumbled by 34.21% to 0.12 in 2018, then jumped by 1204.93% to 1.63 in 2019, then sank by 94.37% to 0.09 in 2020.
- The last three Debt Ratio figures came in at 0.09 (Q1 2020), 1.63 (Q4 2019), and 0.11 (Q3 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Larimar Therapeutics | 452.93 Mn | 296.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 0.09 |
| Dec 31, 2019 | 1.63 |
| Sep 30, 2019 | 0.11 |
| Jun 30, 2019 | 0.11 |
| Mar 31, 2019 | 0.12 |
| Dec 31, 2018 | 0.12 |
| Sep 30, 2018 | 0.16 |
| Jun 30, 2018 | 0.23 |
| Mar 31, 2018 | 0.22 |
| Dec 31, 2017 | 0.19 |
| Sep 30, 2016 | 0.01 |
| Jun 30, 2016 | 0.01 |
| Mar 31, 2016 | 0.02 |
| Dec 31, 2015 | 0.02 |
| Sep 30, 2015 | 0.02 |
| Jun 30, 2015 | 0.02 |
| Mar 31, 2015 | 0.02 |
| Dec 31, 2014 | 0.05 |
| Sep 30, 2014 | 0.05 |
| Jun 30, 2014 | 0.05 |